Plasma concentrations of interleukin-6, C-reactive protein, tumor necrosis factor-α and matrix metalloproteinase-9 in aortic dissection

Clinica Chimica Acta

Volumn 413, Issue 1-2, 2012, Pages 198-202

  Wen, Dan ^a   Zhou, Xian Liang ^a   Li, Jian Jun ^a   Luo, Fang ^a   Zhang, Lin ^a   Gao, Ling Gen ^a   Wang, Lin Ping ^a   Song, Lei ^a   Sun, Kai ^a   Zou, Yu Bao ^a   Zhang, Chan Na ^a   Hui, Ru Tai ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Aortic dissection; C reactive protein; Inflammation; Interleukin 6; Matrix metalloproteinase 9; Tumor necrosis factor

Indexed keywords

C REACTIVE PROTEIN; GELATINASE B; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AORTA DISSECTION; AORTA SURGERY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; STENT; SURVIVAL RATE;

ANEURYSM, DISSECTING; AORTIC ANEURYSM; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; HUMANS; INTERLEUKIN-6; MATRIX METALLOPROTEINASE 9; TUMOR NECROSIS FACTOR-ALPHA;

EID: 82955212819     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.09.029     Document Type: Article

References (23)

1. Spittell P.C., Spittell J.A., Joyce J.W., et al. Clinical features and differential diagnosis of aortic dissection: experience with 236 cases (1980 through 1990). Mayo Clin Proc 1993, 68:642-651.
2. Shimizu K., Mitchell R.N., Libby P. Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2006, 26:987-994.
3. Luo F., Zhou X.L., Li J.J., Hui R.T. Inflammatory response is associated with aortic dissection. Ageing Res Rev 2009, 8:31-35.
4. He R., Guo D.C., Estrera A.L., et al. Characterization of the inflammatory and apoptotic cells in the aortas of patients with ascending thoracic aortic aneurysms and dissections. J Thorac Cardiovasc Surg 2006, 131:671-678.
5. Li J.J., Wang H.R., Huang C.X., Xue J.L., Li G.S. Enhanced inflammatory response of blood monocytes to C-reactive protein in patients with unstable angina. Clin Chim Acta 2005, 352:127-133.
6. Sangiorgi G., Trimarchi S., Mauriello A., et al. Plasma levels of metalloproteinases-9 and -2 in the acute and subacute phases of type A and type B aortic dissection. J Cardiovasc Med (Hagerstown) 2006, 7:307-315.
7. Nagase H., Visse R., Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 2006, 69:562-573.
8. Nienaber C.A., Eagle K.A. Aortic dissection: new frontiers in diagnosis and management: part I: from etiology to diagnostic strategies. Circulation 2003, 108:628-635.
9. Hagan P.G., Nienaber C.A., Isselbacher E.M., et al. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA 2000, 283:897-903.
10. Wen D., Zhou X.L., Li J.J., Hui R.T. Biomarkers in aortic dissection. Clin Chim Acta 2011, 412:688-695.
11. Maksimowicz-McKinnon K., Bhatt D.L., Calabrese L.H. Recent advances in vascular inflammation: C-reactive protein and other inflammatory biomarkers. Curr Opin Rheumatol 2004, 16:18-24.
12. Ridker P.M., Rifai N., Pfeffer M., Sacks F., Lepage S., Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000, 101:2149-2153.
13. Galis Z.S., Sukhova G.K., Lark M.W., Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994, 94:2493-2503.
14. Black P.H., Garbutt L.D. Stress, inflammation and cardiovascular disease. J Psychosom Res 2002, 52:1-23.
15. Yeh E.T. High-sensitivity C-reactive protein as a risk assessment tool for cardiovascular disease. Clin Cardiol 2005, 28:408-412.
16. Schillinger M., Domanovits H., Bayegan K., Holzenbein T., Grabenwoger M., Thoenissen J., Roggla M., Mullner M. C-reactive protein and mortality in patients with acute aortic disease. Intensive Care Med 2002, 28:740-745.
17. Galis Z.S., Sukhova G.K., Lark M.W., Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994, 94:2493-2503.
18. Schneiderman J., Bordin G.M., Adar R., et al. Patterns of expression of fibrinolytic genes and matrix metalloproteinase-9 in dissecting aortic aneurysms. Am J Pathol 1998, 152:703-710.
19. Karapanagiotidis G.T., Antonitsis P., Charokopos N., et al. Serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia. J Cardiothorac Surg 2009, 4:59-64.
20. Manabe T., Imoto K., Uchida K., Doi C., Takanashi Y. Decreased tissue inhibitor of metalloproteinase-2/matrix metalloproteinase ratio in the acute phase of aortic dissection. Surg Today 2004, 34:220-225.
21. Koullias G.J., Ravichandran P., Korkolis D.P., Rimm D.L., Elefteriades J.A. Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections. Ann Thorac Surg 2004, 78:2106-2110. discussion 2110-2111.
22. Karakaya O., Barutcu I., Esen A.M., et al. Relationship between circulating plasma matrix metalloproteinase-9 (gelatinase-B) concentration and aortic root dilatation. Am J Hypertens 2006, 19:361-365.
23. Solini A., Santini E., Passaro A., Madec S., Ferrannini E. Family history of hypertension, anthropometric parameters and markers of early atherosclerosis in young healthy individuals. J Hum Hypertens 2009, 23:801-807.